2023-2029 Global Hypoactive Sexual Desire Disorder Medication Industry Research & Trends Analysis Report
2023-2029 Global Hypoactive Sexual Desire Disorder Medication Industry Research & Trends Analysis Report
Insights into the Hypoactive Sexual Desire Disorder Medication Market include supply chain optimization, Hypoactive Sexual Desire Disorder Medication challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the latest research analysis,the global market for Hypoactive Sexual Desire Disorder Medication should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Hypoactive Sexual Desire Disorder Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Hypoactive Sexual Desire Disorder Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Oral segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Hypoactive Sexual Desire Disorder Medication include Sprout Pharmaceuticals, Inc., Covis Pharma GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Zydus Group, Sun Pharmaceutical Industries Ltd, Abbvie,Inc and EndoCeutics, Inc., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Hypoactive Sexual Desire Disorder Medication.
Data-Driven Insights: Highlights from Our Report
(1) Global Hypoactive Sexual Desire Disorder Medication market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Hypoactive Sexual Desire Disorder Medication market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Hypoactive Sexual Desire Disorder Medication market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Hypoactive Sexual Desire Disorder Medication segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Hypoactive Sexual Desire Disorder Medication segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Hypoactive Sexual Desire Disorder Medication, capacity, production and trends.
(7) Hypoactive Sexual Desire Disorder Medication industry supply chain, upstream, midstream and downstream analysis.
Breaking Down Market Segments by Region: A Deep Dive Analysis
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Understanding Market Segments by Type: A Comparative Analysis
Oral
Parenteral
Others
Market Segmentation by Application: Dividing Key Markets and Identifying Opportunities
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Understanding Market Segments by Key Players: Insights and Opportunities
Sprout Pharmaceuticals, Inc.
Covis Pharma GmbH
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC.
Zydus Group
Sun Pharmaceutical Industries Ltd
Abbvie,Inc
EndoCeutics, Inc.
S1 BIOPHARMA INC.
1 Market Overview
1.1 Hypoactive Sexual Desire Disorder Medication Definition
1.2 Global Hypoactive Sexual Desire Disorder Medication Market Size and Forecast
1.2.1 By Revenue, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
1.2.2 By Sales Volume, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
1.2.3 Global Hypoactive Sexual Desire Disorder Medication Price Trend, 2018-2029
1.3 China Hypoactive Sexual Desire Disorder Medication Market Size and Forecast
1.3.1 By Revenue, China Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
1.3.2 By Sales Volume, China Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
1.3.3 China Hypoactive Sexual Desire Disorder Medication Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Hypoactive Sexual Desire Disorder Medication Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Hypoactive Sexual Desire Disorder Medication Share in Global Market, 2018-2029
1.4.3 Hypoactive Sexual Desire Disorder Medication Market Size: China VS Global, 2018-2029
1.5 Hypoactive Sexual Desire Disorder Medication Market Dynamics
1.5.1 Hypoactive Sexual Desire Disorder Medication Market Drivers
1.5.2 Hypoactive Sexual Desire Disorder Medication Market Restraints
1.5.3 Hypoactive Sexual Desire Disorder Medication Industry Trends
1.5.4 Hypoactive Sexual Desire Disorder Medication Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Hypoactive Sexual Desire Disorder Medication Revenue by Company, 2018-2023
2.2 Global Hypoactive Sexual Desire Disorder Medication Sales Volume by Company, 2018-2023
2.3 Global Hypoactive Sexual Desire Disorder Medication Price by Company, 2018-2023
2.4 Global Hypoactive Sexual Desire Disorder Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Hypoactive Sexual Desire Disorder Medication Concentration Ratio
2.6 Global Hypoactive Sexual Desire Disorder Medication Mergers & Acquisitions, Expansion Plans
2.7 Global Hypoactive Sexual Desire Disorder Medication Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Hypoactive Sexual Desire Disorder Medication Revenue by Company, 2018-2023
3.2 China Hypoactive Sexual Desire Disorder Medication Sales Volume by Company, 2018-2023
3.3 China Hypoactive Sexual Desire Disorder Medication Hypoactive Sexual Desire Disorder Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Hypoactive Sexual Desire Disorder Medication Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Hypoactive Sexual Desire Disorder Medication Domestic VS Export
3.6 China Market, Hypoactive Sexual Desire Disorder Medication Import & Export
3.6.1 China Market, Hypoactive Sexual Desire Disorder Medication Import & Export, 2018-2029
3.6.2 China Hypoactive Sexual Desire Disorder Medication Import & Export Trends
3.6.3 Main Sources of China Hypoactive Sexual Desire Disorder Medication Import
3.6.4 Export Destination of China Hypoactive Sexual Desire Disorder Medication
4 Hypoactive Sexual Desire Disorder Medication Production by Region
4.1 Global Hypoactive Sexual Desire Disorder Medication Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Hypoactive Sexual Desire Disorder Medication Manufacturers
4.3 Global Major Manufacturers, Hypoactive Sexual Desire Disorder Medication Capacity Expansion and Future Plans
4.4 Global Hypoactive Sexual Desire Disorder Medication Capacity by Region
4.5 Global Hypoactive Sexual Desire Disorder Medication Production by Region
4.5.1 Global Hypoactive Sexual Desire Disorder Medication Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Hypoactive Sexual Desire Disorder Medication Production by Region, 2018-2023
4.5.3 Global Hypoactive Sexual Desire Disorder Medication Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Hypoactive Sexual Desire Disorder Medication Industry Chain
5.2 Hypoactive Sexual Desire Disorder Medication Upstream Analysis
5.2.1 Hypoactive Sexual Desire Disorder Medication Core Raw Materials
5.2.2 Main Manufacturers of Hypoactive Sexual Desire Disorder Medication Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Hypoactive Sexual Desire Disorder Medication Production Mode
5.6 Hypoactive Sexual Desire Disorder Medication Procurement Model
5.7 Hypoactive Sexual Desire Disorder Medication Industry Sales Model and Sales Channels
5.7.1 Hypoactive Sexual Desire Disorder Medication Sales Model
5.7.2 Hypoactive Sexual Desire Disorder Medication Typical Distributors
6 Sights by Type
6.1 Hypoactive Sexual Desire Disorder Medication Classification
6.1.1 Oral
6.1.2 Parenteral
6.1.3 Others
6.2 By Type, Global Hypoactive Sexual Desire Disorder Medication Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2018-2029
6.4 By Type, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2018-2029
6.5 By Type, Global Hypoactive Sexual Desire Disorder Medication Price, 2018-2029
7 Sights by Application
7.1 Hypoactive Sexual Desire Disorder Medication Segment by Application
7.1.1 Hospital Pharmacy
7.1.2 Online Pharmacy
7.1.3 Retail Pharmacy
7.2 By Application, Global Hypoactive Sexual Desire Disorder Medication Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2018-2029
7.4 By Application, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2018-2029
7.5 By Application, Global Hypoactive Sexual Desire Disorder Medication Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Hypoactive Sexual Desire Disorder Medication Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2018-2029
8.3 By Region, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.5 Europe
8.5.1 Europe Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.7 South America
8.7.1 South America Hypoactive Sexual Desire Disorder Medication Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Hypoactive Sexual Desire Disorder Medication Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Hypoactive Sexual Desire Disorder Medication Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Hypoactive Sexual Desire Disorder Medication Revenue, 2018-2029
9.3 By Country, Global Hypoactive Sexual Desire Disorder Medication Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.4.2 By Company, U.S. Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.5.2 By Company, Europe Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.5.3 By Type, Europe Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.6.2 By Company, China Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.6.3 By Type, China Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.7.2 By Company, Japan Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.7.3 By Type, Japan Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.8.2 By Company, South Korea Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.10.2 By Company, India Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.10.3 By Type, India Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Hypoactive Sexual Desire Disorder Medication Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sprout Pharmaceuticals, Inc.
10.1.1 Sprout Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.1.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sprout Pharmaceuticals, Inc. Company Profile and Main Business
10.1.5 Sprout Pharmaceuticals, Inc. Recent Developments
10.2 Covis Pharma GmbH
10.2.1 Covis Pharma GmbH Company Information, Head Office, Market Area and Industry Position
10.2.2 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.2.3 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Covis Pharma GmbH Company Profile and Main Business
10.2.5 Covis Pharma GmbH Recent Developments
10.3 Mylan N.V.
10.3.1 Mylan N.V. Company Information, Head Office, Market Area and Industry Position
10.3.2 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.3.3 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Mylan N.V. Company Profile and Main Business
10.3.5 Mylan N.V. Recent Developments
10.4 Teva Pharmaceutical Industries Ltd.
10.4.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area and Industry Position
10.4.2 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.4.3 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.5 Amneal Pharmaceuticals LLC.
10.5.1 Amneal Pharmaceuticals LLC. Company Information, Head Office, Market Area and Industry Position
10.5.2 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.5.3 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Amneal Pharmaceuticals LLC. Company Profile and Main Business
10.5.5 Amneal Pharmaceuticals LLC. Recent Developments
10.6 Zydus Group
10.6.1 Zydus Group Company Information, Head Office, Market Area and Industry Position
10.6.2 Zydus Group Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.6.3 Zydus Group Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Zydus Group Company Profile and Main Business
10.6.5 Zydus Group Recent Developments
10.7 Sun Pharmaceutical Industries Ltd
10.7.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.7.2 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.7.3 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.7.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.8 Abbvie,Inc
10.8.1 Abbvie,Inc Company Information, Head Office, Market Area and Industry Position
10.8.2 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.8.3 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Abbvie,Inc Company Profile and Main Business
10.8.5 Abbvie,Inc Recent Developments
10.9 EndoCeutics, Inc.
10.9.1 EndoCeutics, Inc. Company Information, Head Office, Market Area and Industry Position
10.9.2 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.9.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 EndoCeutics, Inc. Company Profile and Main Business
10.9.5 EndoCeutics, Inc. Recent Developments
10.10 S1 BIOPHARMA INC.
10.10.1 S1 BIOPHARMA INC. Company Information, Head Office, Market Area and Industry Position
10.10.2 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Models, Specifications and Application
10.10.3 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 S1 BIOPHARMA INC. Company Profile and Main Business
10.10.5 S1 BIOPHARMA INC. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Research Methodology:
Hypoactive Sexual Desire Disorder Medication Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|